NewAmsterdam Pharma Co N.V (NAMS) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to 0.04.

  • NewAmsterdam Pharma Co N.V's Asset Utilization Ratio fell 41.97% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 41.97%. This contributed to the annual value of 0.08 for FY2024, which is 7.23% down from last year.
  • Per NewAmsterdam Pharma Co N.V's latest filing, its Asset Utilization Ratio stood at 0.04 for Q3 2025, which was down 43.84% from 0.08 recorded in Q2 2025.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Asset Utilization Ratio ranged from a high of 0.08 in Q2 2025 and a low of 0.02 during Q2 2024.
  • In the last 2 years, NewAmsterdam Pharma Co N.V's Asset Utilization Ratio had a median value of 0.06 in 2025 and averaged 0.05.
  • Examining YoY changes over the last 5 years, NewAmsterdam Pharma Co N.V's Asset Utilization Ratio showed a top increase of 393.56% in 2025 and a maximum decrease of 41.97% in 2025.
  • Over the past 2 years, NewAmsterdam Pharma Co N.V's Asset Utilization Ratio (Quarterly) stood at 0.07 in 2024, then slumped by 41.97% to 0.04 in 2025.
  • Its Asset Utilization Ratio was 0.04 in Q3 2025, compared to 0.08 in Q2 2025 and 0.06 in Q1 2025.